Mahsa Zarei

1.2k total citations
32 papers, 813 citations indexed

About

Mahsa Zarei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mahsa Zarei has authored 32 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Mahsa Zarei's work include RNA modifications and cancer (4 papers), Nuclear Receptors and Signaling (4 papers) and Phytochemistry and Bioactivity Studies (3 papers). Mahsa Zarei is often cited by papers focused on RNA modifications and cancer (4 papers), Nuclear Receptors and Signaling (4 papers) and Phytochemistry and Bioactivity Studies (3 papers). Mahsa Zarei collaborates with scholars based in United States, India and Iran. Mahsa Zarei's co-authors include T. Shivanandappa, Jordan M. Winter, Jonathan R. Brody, Ali Vaziri‐Gohar, Charles J. Yeo, Saswati N. Chand, Shubha Gopal, Shruti Lal, Ehsan Karimi and Ehsan Oskoueian and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Cancer Research.

In The Last Decade

Mahsa Zarei

31 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahsa Zarei United States 16 402 203 170 94 67 32 813
Lan Yang China 23 595 1.5× 216 1.1× 204 1.2× 134 1.4× 52 0.8× 55 1.2k
Zihang Xu China 15 454 1.1× 144 0.7× 181 1.1× 113 1.2× 78 1.2× 67 834
İlhan Yaylım Türkiye 17 395 1.0× 144 0.7× 160 0.9× 72 0.8× 64 1.0× 76 798
Shakti Ranjan Satapathy India 22 606 1.5× 285 1.4× 141 0.8× 99 1.1× 73 1.1× 45 1.2k
Amit Singh Yadav India 18 528 1.3× 216 1.1× 194 1.1× 117 1.2× 55 0.8× 40 1.3k
Ruoqiu Fu China 15 498 1.2× 142 0.7× 103 0.6× 49 0.5× 51 0.8× 26 1.2k
Kui Zhao China 17 651 1.6× 161 0.8× 336 2.0× 88 0.9× 54 0.8× 36 1.1k
Sha Zeng China 17 653 1.6× 285 1.4× 280 1.6× 87 0.9× 65 1.0× 32 1.2k
Bijesh Kumar Biswal India 18 541 1.3× 140 0.7× 144 0.8× 42 0.4× 59 0.9× 49 966
Joon‐Seok Choi South Korea 20 569 1.4× 182 0.9× 114 0.7× 67 0.7× 58 0.9× 50 990

Countries citing papers authored by Mahsa Zarei

Since Specialization
Citations

This map shows the geographic impact of Mahsa Zarei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahsa Zarei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahsa Zarei more than expected).

Fields of papers citing papers by Mahsa Zarei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahsa Zarei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahsa Zarei. The network helps show where Mahsa Zarei may publish in the future.

Co-authorship network of co-authors of Mahsa Zarei

This figure shows the co-authorship network connecting the top 25 collaborators of Mahsa Zarei. A scholar is included among the top collaborators of Mahsa Zarei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahsa Zarei. Mahsa Zarei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Heng-Jia, Heng Du, Damir Khabibullin, et al.. (2023). mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion. Nature Communications. 14(1). 1214–1214. 55 indexed citations
2.
3.
Yang, Eddy S., Amin H. Nassar, Elio Adib, et al.. (2021). Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting Agent. Molecular Cancer Therapeutics. 20(8). 1454–1461. 6 indexed citations
4.
Zarei, Mehrdad, T. Shivanandappa, & Mahsa Zarei. (2020). Natural bioactive 4-Hydroxyisophthalic acid (4-HIPA) exhibited antiproliferative potential by upregulating apoptotic markers in in vitro and in vivo cancer models. Molecular Biology Reports. 47(7). 5343–5353. 7 indexed citations
5.
Zarei, Mahsa, Ehsan Karimi, Ehsan Oskoueian, Ali Es‐haghi, & Mohammad Ehsan Taghavizadeh Yazdi. (2020). Comparative Study on the Biological Effects of Sodium Citrate-Based and Apigenin-Based Synthesized Silver Nanoparticles. Nutrition and Cancer. 73(8). 1511–1519. 53 indexed citations
6.
Zarei, Mahsa, Ali Es‐haghi, & Ehsan Karimi. (2019). Evaluation of Anti-oxidant and Anti-cancer Properties of Silver Nanoparticles Synthesized by Apigenin toward Breast Cancer MCF-7 Cell Line. Journal of North Khorasan University of Medical Sciences. 11(3). 5–13. 1 indexed citations
7.
Zarei, Mahsa, Heng Du, Amin H. Nassar, et al.. (2019). Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion. The Journal of Experimental Medicine. 216(11). 2635–2652. 17 indexed citations
8.
Karki, Keshav, Xi Li, Un-Ho Jin, et al.. (2019). Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas. Journal of Neuro-Oncology. 146(1). 25–39. 25 indexed citations
9.
Hedrick, Erik, et al.. (2019). Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists. Breast Cancer Research and Treatment. 177(1). 29–40. 26 indexed citations
10.
Zarei, Mahsa, Shruti Lal, Ali Vaziri‐Gohar, et al.. (2018). RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer. Molecular Cancer Research. 17(2). 508–520. 15 indexed citations
11.
Lal, Shruti, Edwin Cheung, Mahsa Zarei, et al.. (2017). CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype. Molecular Cancer Research. 15(6). 696–707. 41 indexed citations
12.
Chand, Saswati N., Mahsa Zarei, Matthew J. Schiewer, et al.. (2017). Posttranscriptional Regulation of PARG mRNA by HuR Facilitates DNA Repair and Resistance to PARP Inhibitors. Cancer Research. 77(18). 5011–5025. 64 indexed citations
13.
Zarei, Mahsa, Shruti Lal, Seth J. Parker, et al.. (2017). Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells. Cancer Research. 77(16). 4460–4471. 84 indexed citations
14.
Zarei, Mahsa, Saswati N. Chand, Jordan M. Winter, et al.. (2016). HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells. Molecular Cancer Research. 14(7). 599–611. 48 indexed citations
15.
Zarei, Mahsa & T. Shivanandappa. (2016). Neuroprotective effect of Decalepis hamiltonii on cyclophosphamide-induced oxidative stress in the mouse brain. Journal of Basic and Clinical Physiology and Pharmacology. 27(4). 341–348. 19 indexed citations
16.
Baker, Syed, M. N. Nagendra Prasad, H.C. Yashavantha Rao, et al.. (2015). Actinomycetic Symbionts InhabitingEuphorbia hirtaL. with Antimicrobial Potentials. Journal of Biologically Active Products from Nature. 5(6). 419–426. 2 indexed citations
17.
Zarei, Mahsa, Ashwini Kumar, Mehrdad Zarei, & Syed Baker. (2013). Cardioprotective effect of the root extract of Hemidesmus indicus against doxorubicin -induced oxidative stress in mice. Der pharmacia lettre. 5(1). 334–339. 4 indexed citations
18.
Zarei, Mahsa. (2013). ANTITUMOR EFFECT OF DECALEPIS HAMILTONII ROOT EXTRACT AGAINST EHRLICH ASCITES TUMOR IN MICE. International Journal of Pharma and Bio Sciences. 1 indexed citations
19.
Zarei, Mahsa & Ashwini Kumar. (2012). Anticarcinogenic and cytotoxic potential of Hemidesmus indicus root extract against Ehrlich Ascites tumor. Der pharmacia lettre. 4(3). 906–910. 10 indexed citations
20.
Etemadi, Arash, Asieh Golozar, Akhgar Ghassabian, et al.. (2011). Cavernous hemangioma of the liver. European Journal of Gastroenterology & Hepatology. 23(4). 354–358. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lan Yang Breakdown of academic impact, for papers by Zihang Xu Breakdown of academic impact, for papers by İlhan Yaylım Breakdown of academic impact, for papers by Shakti Ranjan Satapathy Breakdown of academic impact, for papers by Amit Singh Yadav Breakdown of academic impact, for papers by Ruoqiu Fu Breakdown of academic impact, for papers by Kui Zhao Breakdown of academic impact, for papers by Sha Zeng Breakdown of academic impact, for papers by Bijesh Kumar Biswal Breakdown of academic impact, for papers by Joon‐Seok Choi
Rankless by CCL
2026